Source: Annual Congress 2012 - Cystic fibrosis (adults and children): new basic and clinical physiology research
Disease area: Paediatric lung diseases



Rating:

Share or cite this content

Citations should be made in the following way:
L. Tepper, E. Utens, D. Caudri, A. Quittner, H. Tiddens (Rotterdam, Netherlands; Miami, United States Of America). Tracking disease progression in cystic fibrosis using bronchiectasis, trapped air and quality of life. Eur Respir J 2012; 40: Suppl. 56, 1450

Member's Comments

No comment yet.

Related content which might interest you: Impact of bronchiectasis and trapped air on quality of life and exacerbations in cystic fibrosis Source: Eur Respir J 2013; 42: 371-379 Year: 2013 Understanding patients’ experience of living with non-cystic fibrosis bronchiectasis Source: Annual Congress 2013 –Aspects of physiotherapy in various clinical conditions and settings Year: 2013 Treatment of advanced cystic fibrosis lung disease and end of life decisions Source: School Course 2013 - Cystic Fibrosis Year: 2013 Home versus hospital treatment of acute cystic fibrosis pulmonary exacerbations – Is quality of life really better at home? Source: Annual Congress 2013 –Cystic fibrosis: physiotherapy, exercise and lung function in adults and children Year: 2013 Patient reported quality of life in advanced cystic fibrosis (CF) lung disease assessed for lung transplantation Source: Annual Congress 2008 - Lung and bone marrow transplantation: miscellaneous Year: 2008 Early detection of pulmonary exacerbations in children with cystic fibrosis by electronic home monitoring of symptoms and lung function Source: International Congress 2016 – Cystic fibrosis: monitoring and management Year: 2016 Pulmonary function, inflammation, exercise capacity and quality of life in cystic fibrosis Source: Eur Respir J 2001; 17: 712-715 Year: 2001 Monitoring early lung disease in cystic fibrosis: where are we now? Source: Breathe 2014; 10: 34-47 Year: 2014 Improving airway clearance in cystic fibrosis lung disease Source: Eur Respir Monogr 2014; 64: 169-187 Year: 2014 Factors affecting progression of lung disease among patients with cystic fibrosis Source: International Congress 2019 – Physiology of cystic fibrosis Year: 2019 Health-related quality of life and health status among patients with sarcoidosis, chronic obstructive pulmonary disease and interstitial lung disease Source: International Congress 2018 – Granulomatous disorders: heterogeneous diseases with variable management Year: 2018 Quality of life of patients with idiopathic pulmonary fibrosis (IPF) - What can the Australian IPF registry tell us? Source: International Congress 2015 – IPF: clinical aspects II Year: 2015 Quality of life in children with cystic fibrosis and asthma Source: Eur Respir J 2002; 20: Suppl. 38, 342s Year: 2002 Early cystic fibrosis lung disease Source: Eur Respir Monogr 2014; 64: 77-87 Year: 2014 Do causes influence clinical, functional and quality of life aspects on patients with bronchiectasis not associated with cystic fibrosis? Source: International Congress 2019 – Chronic cough, a1-antitrypsin deficiency and other conditions Year: 2019 Effect of nintedanib on cough and health related quality of life in patients with idiopathic pulmonary fibrosis Source: International Congress 2016 – IPF: from pathogenesis to treatment I Year: 2016 The burden of idiopathic pulmonary fibrosis reported by patients and carers in Ireland Source: International Congress 2015 – IPF: clinical aspects Year: 2015 Global impact of bronchiectasis and cystic fibrosis Source: Breathe 2016; 12: 222-235 Year: 2016 Evolution of lung clearance index during the first year of life in cystic fibrosis Source: Virtual Congress 2021 – Monitoring of lung disease and CFTR function in children with cystic fibrosis Year: 2021 Inflammation and infection in infants with cystic fibrosis is associated with changes in lung function in the first year of life Source: Annual Congress 2008 - Respiratory physiology in health and disease Year: 2008